25 XP   0   0   10

Merck & Company Inc
Buy, Hold or Sell?

Let's analyse Merck & Company Inc together

PenkeI guess you are interested in Merck & Company Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Merck & Company Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Merck & Company Inc

I send you an email if I find something interesting about Merck & Company Inc.

Quick analysis of Merck & Company Inc (30 sec.)










What can you expect buying and holding a share of Merck & Company Inc? (30 sec.)

How much money do you get?

How much money do you get?
€7.93
When do you have the money?
1 year
How often do you get paid?
92.9%

What is your share worth?

Current worth
€65.08
Expected worth in 1 year
€64.98
How sure are you?
75.0%

+ What do you gain per year?

Total Gains per Share
€7.23
Return On Investment
4.4%

For what price can you sell your share?

Current Price per Share
€162.90
Expected price per share
€146.75 - €170.70
How sure are you?
50%

1. Valuation of Merck & Company Inc (5 min.)




Live pricePrice per Share (EOD)

€162.90

Intrinsic Value Per Share

€32.20 - €36.26

Total Value Per Share

€97.28 - €101.34

2. Growth of Merck & Company Inc (5 min.)




Is Merck & Company Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$30.6b$26.7b$2.3b7.9%

How much money is Merck & Company Inc making?

Current yearPrevious yearGrowGrow %
Making money$782.6m$938.9m-$156.3m-20.0%
Net Profit Margin13.5%15.9%--

How much money comes from the company's main activities?

3. Financial Health of Merck & Company Inc (5 min.)




What can you expect buying and holding a share of Merck & Company Inc? (5 min.)

Welcome investor! Merck & Company Inc's management wants to use your money to grow the business. In return you get a share of Merck & Company Inc.

What can you expect buying and holding a share of Merck & Company Inc?

First you should know what it really means to hold a share of Merck & Company Inc. And how you can make/lose money.

Speculation

The Price per Share of Merck & Company Inc is €162.90. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Merck & Company Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Merck & Company Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €65.08. Based on the TTM, the Book Value Change Per Share is €-0.02 per quarter. Based on the YOY, the Book Value Change Per Share is €4.40 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €1.83 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Merck & Company Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps1.841.1%1.741.1%2.161.3%2.071.3%1.931.2%
Usd Book Value Change Per Share3.792.3%-0.030.0%4.762.9%0.300.2%2.511.5%
Usd Dividend Per Share0.000.0%1.981.2%1.310.8%1.080.7%1.030.6%
Usd Total Gains Per Share3.792.3%1.961.2%6.073.7%1.380.8%3.552.2%
Usd Price Per Share171.23-179.70-201.21-154.45-139.21-
Price to Earnings Ratio23.28-25.88-23.50-24.32-22.02-
Price-to-Total Gains Ratio45.19-20.60-52.17-234.13-168.32-
Price to Book Ratio2.43-2.70-3.36-2.73-2.57-
Price-to-Total Gains Ratio45.19-20.60-52.17-234.13-168.32-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share176.20893
Number of shares5
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share1.981.08
Usd Book Value Change Per Share-0.030.30
Usd Total Gains Per Share1.961.38
Gains per Quarter (5 shares)9.786.88
Gains per Year (5 shares)39.1127.54
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
140-12922618
279-168431246
3119-2107651874
4159-21468624102
5198-318510830130
6238-322413036158
7277-426315142186
8317-430217348214
9357-534119454242
10396-538021659270

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%28.00.00.0100.0%28.00.00.0100.0%
Book Value Change Per Share3.01.00.075.0%10.02.00.083.3%14.06.00.070.0%18.010.00.064.3%18.010.00.064.3%
Dividend per Share3.00.01.075.0%11.00.01.091.7%18.00.02.090.0%26.00.02.092.9%26.00.02.092.9%
Total Gains per Share3.01.00.075.0%10.02.00.083.3%17.03.00.085.0%21.07.00.075.0%21.07.00.075.0%

Fundamentals of Merck & Company Inc

About Merck & Company Inc

Merck KGaA operates as a science and technology company in Germany. The company's Life Science segment offers a range of products, including reagents, consumable, devices, instruments, software, and services for scientific discovery, as well as provides lab water instruments, consumables and services, microbiology and biomonitoring, products, test assays, analytical reagents, and flow cytometry kits and instruments for pharma and biotech, industrial and testing, academics and government, and diagnostic sectors. Its Healthcare segment designs and develops medicines and intelligent devices for treatment of various therapeutics, such as oncology, neurology and immunology, endocrinology, and general medicines. The company's Electronic segment provides semiconductor solutions, such as semiconductor materials, delivery systems and services, and intermolecular services for semiconductor and polymer removal chemistries applications; and display solutions comprising liquid crystals, OLED and quantum materials, reactive mesogens, photoresist materials, smart antenna, and dynamic liquid crystal glazing products, as well as offers liviFlex, a flexible platform, which offers a range of display materials. This segment also provides surface solution, such as cosmetics, effect pigments, and functional solutions; architecture solutions, including switchable windows; and automotive solutions. In addition, it has strategic alliances with Pfizer Inc. and GlaxoSmihKline plc to develop and commercialize active ingredients in immune-oncology; in-licensing agreement with Debiopharm International SA for developing drug candidates for the treatment of head and neck cancer; out-licensing agreement with MoonLake; and Immunotherapeutics AG for developing a drug candidate for the treatment of inflammatory diseases. The company was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KGaA operates as a subsidiary of E. Merck KG.

Fundamental data was last updated by Penke on 2024-03-14 03:59:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is overpriced.

1.1. Profitability of Merck & Company Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Merck & Company Inc earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Merck & Company Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 14.3% means that €0.14 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Merck & Company Inc:

  • The MRQ is 14.3%. The company is making a huge profit. +2
  • The TTM is 13.5%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ14.3%TTM13.5%+0.7%
TTM13.5%YOY15.9%-2.4%
TTM13.5%5Y15.3%-1.7%
5Y15.3%10Y14.5%+0.8%
1.1.2. Return on Assets

Shows how efficient Merck & Company Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Merck & Company Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.5% Return on Assets means that Merck & Company Inc generated €0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Merck & Company Inc:

  • The MRQ is 1.5%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.5%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.5%TTM1.5%+0.0%
TTM1.5%YOY1.8%-0.3%
TTM1.5%5Y1.6%-0.2%
5Y1.6%10Y1.5%+0.1%
1.1.3. Return on Equity

Shows how efficient Merck & Company Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Merck & Company Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • 2.6% Return on Equity means Merck & Company Inc generated €0.03 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Merck & Company Inc:

  • The MRQ is 2.6%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.7%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.6%TTM2.7%-0.1%
TTM2.7%YOY3.6%-0.8%
TTM2.7%5Y3.5%-0.8%
5Y3.5%10Y3.4%+0.0%

1.2. Operating Efficiency of Merck & Company Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Merck & Company Inc is operating .

  • Measures how much profit Merck & Company Inc makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Merck & Company Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Merck & Company Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM10.9%-10.9%
TTM10.9%YOY22.3%-11.4%
TTM10.9%5Y20.2%-9.3%
5Y20.2%10Y18.3%+1.9%
1.2.2. Operating Ratio

Measures how efficient Merck & Company Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.22 means that the operating costs are €1.22 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Merck & Company Inc:

  • The MRQ is 1.222. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.204. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.222TTM1.204+0.018
TTM1.204YOY1.164+0.040
TTM1.2045Y1.209-0.005
5Y1.20910Y1.210-0.001

1.3. Liquidity of Merck & Company Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Merck & Company Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.56 means the company has €1.56 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Merck & Company Inc:

  • The MRQ is 1.562. The company is able to pay all its short-term debts. +1
  • The TTM is 1.418. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.562TTM1.418+0.144
TTM1.418YOY1.198+0.220
TTM1.4185Y1.140+0.278
5Y1.14010Y1.072+0.068
1.3.2. Quick Ratio

Measures if Merck & Company Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Merck & Company Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.51 means the company can pay off €0.51 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Merck & Company Inc:

  • The MRQ is 0.508. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.562. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.508TTM0.562-0.054
TTM0.562YOY0.500+0.062
TTM0.5625Y0.459+0.104
5Y0.45910Y0.446+0.013

1.4. Solvency of Merck & Company Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Merck & Company Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Merck & Company Inc to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.43 means that Merck & Company Inc assets are financed with 43.3% credit (debt) and the remaining percentage (100% - 43.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Merck & Company Inc:

  • The MRQ is 0.433. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.452. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.433TTM0.452-0.019
TTM0.452YOY0.485-0.033
TTM0.4525Y0.527-0.075
5Y0.52710Y0.550-0.023
1.4.2. Debt to Equity Ratio

Measures if Merck & Company Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Merck & Company Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 76.6% means that company has €0.77 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Merck & Company Inc:

  • The MRQ is 0.766. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.829. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.766TTM0.829-0.063
TTM0.829YOY0.953-0.124
TTM0.8295Y1.143-0.314
5Y1.14310Y1.261-0.118

2. Market Valuation of Merck & Company Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Merck & Company Inc generates.

  • Above 15 is considered overpriced but always compare Merck & Company Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 23.28 means the investor is paying €23.28 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Merck & Company Inc:

  • The EOD is 23.960. Based on the earnings, the company is fair priced.
  • The MRQ is 23.283. Based on the earnings, the company is fair priced.
  • The TTM is 25.885. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD23.960MRQ23.283+0.677
MRQ23.283TTM25.885-2.601
TTM25.885YOY23.499+2.385
TTM25.8855Y24.320+1.564
5Y24.32010Y22.015+2.305
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Merck & Company Inc:

  • The EOD is 22.328. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 21.698. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 52.843. Based on how much money comes from the company's main activities, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD22.328MRQ21.698+0.631
MRQ21.698TTM52.843-31.146
TTM52.843YOY35.246+17.598
TTM52.8435Y33.013+19.831
5Y33.01310Y30.147+2.865
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Merck & Company Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 2.43 means the investor is paying €2.43 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Merck & Company Inc:

  • The EOD is 2.503. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.432. Based on the equity, the company is underpriced. +1
  • The TTM is 2.700. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.503MRQ2.432+0.071
MRQ2.432TTM2.700-0.267
TTM2.700YOY3.362-0.662
TTM2.7005Y2.729-0.029
5Y2.72910Y2.571+0.158
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Merck & Company Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--3.503-0.024+101%4.403-20%0.275+1175%2.324+51%
Book Value Per Share--65.07961.699+5%56.795+15%54.502+19%53.845+21%
Current Ratio--1.5621.418+10%1.198+30%1.140+37%1.072+46%
Debt To Asset Ratio--0.4330.452-4%0.485-11%0.527-18%0.550-21%
Debt To Equity Ratio--0.7660.829-8%0.953-20%1.143-33%1.261-39%
Dividend Per Share---1.832-100%1.213-100%0.998-100%0.955-100%
Eps--1.7001.611+5%1.996-15%1.915-11%1.781-5%
Free Cash Flow Per Share--1.8241.019+79%1.577+16%1.430+28%1.428+28%
Free Cash Flow To Equity Per Share--1.8240.066+2658%0.785+132%0.611+198%0.542+237%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--36.264--------
Intrinsic Value_10Y_min--32.205--------
Intrinsic Value_1Y_max--5.473--------
Intrinsic Value_1Y_min--5.377--------
Intrinsic Value_3Y_max--15.043--------
Intrinsic Value_3Y_min--14.389--------
Intrinsic Value_5Y_max--22.922--------
Intrinsic Value_5Y_min--21.397--------
Market Cap21053521800.000-227%68825337929.10072227474816.625-5%80874119845.463-15%58652380566.215+17%50719347754.618+36%
Net Profit Margin--0.1430.135+5%0.159-10%0.153-6%0.145-1%
Operating Margin---0.109-100%0.223-100%0.202-100%0.183-100%
Operating Ratio--1.2221.204+2%1.164+5%1.209+1%1.210+1%
Pb Ratio2.503+3%2.4322.700-10%3.362-28%2.729-11%2.571-5%
Pe Ratio23.960+3%23.28325.885-10%23.499-1%24.320-4%22.015+6%
Price Per Share162.900+3%158.300166.125-5%186.013-15%142.788+11%128.697+23%
Price To Free Cash Flow Ratio22.328+3%21.69852.843-59%35.246-38%33.013-34%30.147-28%
Price To Total Gains Ratio46.504+3%45.19120.598+119%52.170-13%234.131-81%168.323-73%
Quick Ratio--0.5080.562-10%0.500+2%0.459+11%0.446+14%
Return On Assets--0.0150.015+0%0.018-18%0.016-10%0.015-4%
Return On Equity--0.0260.027-3%0.036-26%0.035-24%0.034-24%
Total Gains Per Share--3.5031.808+94%5.616-38%1.273+175%3.280+7%
Usd Book Value--30606701500.00029017143350.000+5%26710418100.000+15%23002999520.000+33%20854094300.000+47%
Usd Book Value Change Per Share--3.789-0.026+101%4.763-20%0.297+1175%2.514+51%
Usd Book Value Per Share--70.39666.740+5%61.435+15%58.955+19%58.244+21%
Usd Dividend Per Share---1.982-100%1.312-100%1.079-100%1.033-100%
Usd Eps--1.8391.743+5%2.160-15%2.072-11%1.926-5%
Usd Free Cash Flow--857788100.000479463525.000+79%741775775.000+16%601317030.000+43%552014689.286+55%
Usd Free Cash Flow Per Share--1.9731.103+79%1.706+16%1.547+28%1.545+28%
Usd Free Cash Flow To Equity Per Share--1.9730.072+2658%0.850+132%0.661+198%0.586+237%
Usd Market Cap22773594531.060-227%74448368037.90878128459509.143-5%87481535436.837-15%63444280058.474+17%54863118466.170+36%
Usd Price Per Share176.209+3%171.233179.697-5%201.210-15%154.454+11%139.211+23%
Usd Profit--799376300.000782609950.000+2%938915600.000-15%777363705.000+3%701946035.714+14%
Usd Revenue--5595634100.0005794666900.000-3%5891208625.000-5%5152137100.000+9%4843118589.286+16%
Usd Total Gains Per Share--3.7891.956+94%6.075-38%1.377+175%3.547+7%
 EOD+2 -6MRQTTM+25 -10YOY+16 -195Y+24 -1110Y+23 -12

3.2. Fundamental Score

Let's check the fundamental score of Merck & Company Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1523.960
Price to Book Ratio (EOD)Between0-12.503
Net Profit Margin (MRQ)Greater than00.143
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.508
Current Ratio (MRQ)Greater than11.562
Debt to Asset Ratio (MRQ)Less than10.433
Debt to Equity Ratio (MRQ)Less than10.766
Return on Equity (MRQ)Greater than0.150.026
Return on Assets (MRQ)Greater than0.050.015
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Merck & Company Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5060.576
Ma 20Greater thanMa 50158.760
Ma 50Greater thanMa 100155.043
Ma 100Greater thanMa 200151.696
OpenGreater thanClose160.000
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in EUR. All numbers in thousands.

Summary
Total Assets49,906,000
Total Liabilities21,611,000
Total Stockholder Equity28,222,000
 As reported
Total Liabilities 21,611,000
Total Stockholder Equity+ 28,222,000
Total Assets = 49,906,000

Assets

Total Assets49,906,000
Total Current Assets13,566,000
Long-term Assets36,340,000
Total Current Assets
Cash And Cash Equivalents 2,365,000
Short-term Investments 218,000
Net Receivables 4,195,000
Inventory 4,971,000
Other Current Assets 1,141,000
Total Current Assets  (as reported)13,566,000
Total Current Assets  (calculated)12,890,000
+/- 676,000
Long-term Assets
Property Plant Equipment 8,719,000
Goodwill 18,466,000
Intangible Assets 6,716,000
Long-term Assets Other 98,000
Long-term Assets  (as reported)36,340,000
Long-term Assets  (calculated)33,999,000
+/- 2,341,000

Liabilities & Shareholders' Equity

Total Current Liabilities8,685,000
Long-term Liabilities12,926,000
Total Stockholder Equity28,222,000
Total Current Liabilities
Accounts payable 2,244,000
Other Current Liabilities 1,619,000
Total Current Liabilities  (as reported)8,685,000
Total Current Liabilities  (calculated)3,863,000
+/- 4,822,000
Long-term Liabilities
Long-term Liabilities Other 18,000
Long-term Liabilities  (as reported)12,926,000
Long-term Liabilities  (calculated)18,000
+/- 12,908,000
Total Stockholder Equity
Retained Earnings 20,711,000
Total Stockholder Equity (as reported)28,222,000
Total Stockholder Equity (calculated)20,711,000
+/- 7,511,000
Other
Capital Stock565,000
Common Stock Shares Outstanding 434,778
Net Invested Capital 28,222,000
Net Working Capital 4,881,000



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
> Total Assets 
38,251,000
38,351,000
36,774,000
35,830,000
35,621,000
35,175,000
35,828,000
35,740,000
36,888,000
38,717,000
39,568,000
42,067,000
43,811,000
44,743,000
43,822,000
43,231,000
41,796,000
43,891,000
43,145,000
43,836,000
45,362,000
46,235,000
48,717,000
50,933,000
48,526,000
48,637,000
48,782,000
49,906,000
49,906,00048,782,00048,637,00048,526,00050,933,00048,717,00046,235,00045,362,00043,836,00043,145,00043,891,00041,796,00043,231,00043,822,00044,743,00043,811,00042,067,00039,568,00038,717,00036,888,00035,740,00035,828,00035,175,00035,621,00035,830,00036,774,00038,351,00038,251,000
   > Total Current Assets 
7,670,000
8,029,000
7,878,000
7,527,000
7,455,000
7,807,000
8,179,000
8,355,000
9,236,000
10,512,000
11,694,000
13,518,000
9,004,000
10,013,000
9,726,000
10,258,000
9,280,000
10,617,000
10,182,000
10,315,000
10,982,000
11,085,000
12,416,000
12,943,000
12,201,000
12,951,000
13,019,000
13,566,000
13,566,00013,019,00012,951,00012,201,00012,943,00012,416,00011,085,00010,982,00010,315,00010,182,00010,617,0009,280,00010,258,0009,726,00010,013,0009,004,00013,518,00011,694,00010,512,0009,236,0008,355,0008,179,0007,807,0007,455,0007,527,0007,878,0008,029,0007,670,000
       Cash And Cash Equivalents 
939,000
1,031,000
1,041,000
852,000
589,000
747,000
609,000
833,000
2,170,000
2,340,000
3,451,000
5,111,000
541,000
1,530,000
1,512,000
1,548,000
1,110,000
2,238,000
1,825,000
1,523,000
1,511,000
1,339,000
1,580,000
1,604,000
1,398,000
1,584,000
1,761,000
2,365,000
2,365,0001,761,0001,584,0001,398,0001,604,0001,580,0001,339,0001,511,0001,523,0001,825,0002,238,0001,110,0001,548,0001,512,0001,530,000541,0005,111,0003,451,0002,340,0002,170,000833,000609,000747,000589,000852,0001,041,0001,031,000939,000
       Short-term Investments 
43,000
114,000
91,000
96,000
35,000
72,000
120,000
61,000
0
64,000
154,000
275,000
29,000
81,000
32,000
85,000
29,000
691,000
45,000
142,000
112,000
106,000
133,000
347,000
244,000
1,653,000
166,000
218,000
218,000166,0001,653,000244,000347,000133,000106,000112,000142,00045,000691,00029,00085,00032,00081,00029,000275,000154,00064,000061,000120,00072,00035,00096,00091,000114,00043,000
       Net Receivables 
3,812,000
3,548,000
3,399,000
3,267,000
3,945,000
3,536,000
3,447,000
3,354,000
4,056,000
3,616,000
3,468,000
3,440,000
4,574,000
4,406,000
4,060,000
4,098,000
4,278,000
3,654,000
4,124,000
4,207,000
4,772,000
4,705,000
4,867,000
4,796,000
5,034,000
4,270,000
4,846,000
4,195,000
4,195,0004,846,0004,270,0005,034,0004,796,0004,867,0004,705,0004,772,0004,207,0004,124,0003,654,0004,278,0004,098,0004,060,0004,406,0004,574,0003,440,0003,468,0003,616,0004,056,0003,354,0003,447,0003,536,0003,945,0003,267,0003,399,0003,548,0003,812,000
       Inventory 
2,607,000
2,705,000
2,699,000
2,696,000
2,632,000
2,704,000
2,708,000
2,814,000
2,764,000
2,937,000
3,033,000
3,135,000
3,342,000
3,443,000
3,537,000
3,428,000
3,294,000
3,462,000
3,564,000
3,760,000
3,900,000
4,143,000
4,474,000
4,860,000
4,632,000
4,890,000
4,996,000
4,971,000
4,971,0004,996,0004,890,0004,632,0004,860,0004,474,0004,143,0003,900,0003,760,0003,564,0003,462,0003,294,0003,428,0003,537,0003,443,0003,342,0003,135,0003,033,0002,937,0002,764,0002,814,0002,708,0002,704,0002,632,0002,696,0002,699,0002,705,0002,607,000
       Other Current Assets 
198,000
631,000
648,000
616,000
155,000
748,000
1,295,000
1,293,000
121,000
1,126,000
1,284,000
1,232,000
125,000
553,000
585,000
1,099,000
189,000
1,263,000
624,000
683,000
157,000
792,000
1,495,000
1,336,000
226,000
-1,000
1,416,000
1,141,000
1,141,0001,416,000-1,000226,0001,336,0001,495,000792,000157,000683,000624,0001,263,000189,0001,099,000585,000553,000125,0001,232,0001,284,0001,126,000121,0001,293,0001,295,000748,000155,000616,000648,000631,000198,000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
28,204,000
27,874,000
28,550,000
34,808,000
34,730,000
34,096,000
32,973,000
32,516,000
33,273,000
32,963,000
33,521,000
34,380,000
35,149,000
36,301,000
37,990,000
36,325,000
35,686,000
35,763,000
36,340,000
36,340,00035,763,00035,686,00036,325,00037,990,00036,301,00035,149,00034,380,00033,521,00032,963,00033,273,00032,516,00032,973,00034,096,00034,730,00034,808,00028,550,00027,874,00028,204,000000000000
       Property Plant Equipment 
4,230,000
4,218,000
4,211,000
4,242,000
4,512,000
4,468,000
4,483,000
4,549,000
4,811,000
5,291,000
5,251,000
5,376,000
6,213,000
6,110,000
6,067,000
6,027,000
6,421,000
6,552,000
6,601,000
6,761,000
7,217,000
7,303,000
7,573,000
7,946,000
8,203,000
8,218,000
8,393,000
8,719,000
8,719,0008,393,0008,218,0008,203,0007,946,0007,573,0007,303,0007,217,0006,761,0006,601,0006,552,0006,421,0006,027,0006,067,0006,110,0006,213,0005,376,0005,251,0005,291,0004,811,0004,549,0004,483,0004,468,0004,512,0004,242,0004,211,0004,218,0004,230,000
       Goodwill 
15,064,000
0
0
13,720,500
13,582,000
13,282,000
13,614,000
13,597,000
13,764,000
13,966,000
13,841,000
14,309,000
17,141,000
17,376,000
17,118,000
16,512,000
15,959,000
16,541,000
16,347,000
16,670,000
17,004,000
17,761,000
18,573,000
19,534,000
18,415,000
18,077,000
18,102,000
18,466,000
18,466,00018,102,00018,077,00018,415,00019,534,00018,573,00017,761,00017,004,00016,670,00016,347,00016,541,00015,959,00016,512,00017,118,00017,376,00017,141,00014,309,00013,841,00013,966,00013,764,00013,597,00013,614,00013,282,00013,582,00013,720,5000015,064,000
       Long Term Investments 
191,000
221,000
281,000
497,000
419,000
457,000
441,000
468,000
328,000
595,000
657,000
641,000
458,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000458,000641,000657,000595,000328,000468,000441,000457,000419,000497,000281,000221,000191,000
       Intangible Assets 
9,738,000
24,664,000
23,141,000
8,662,500
8,317,000
7,880,000
7,883,000
7,586,000
7,237,000
7,052,000
6,770,000
6,730,000
9,175,000
9,089,000
8,664,000
8,172,000
7,653,000
7,765,000
7,613,000
7,628,000
7,612,000
7,549,000
7,862,000
8,080,000
7,300,000
6,954,000
6,765,000
6,716,000
6,716,0006,765,0006,954,0007,300,0008,080,0007,862,0007,549,0007,612,0007,628,0007,613,0007,765,0007,653,0008,172,0008,664,0009,089,0009,175,0006,730,0006,770,0007,052,0007,237,0007,586,0007,883,0007,880,0008,317,0008,662,50023,141,00024,664,0009,738,000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
81,000
87,000
91,000
80,000
94,000
91,000
91,000
62,000
84,000
87,000
84,000
74,000
104,000
99,000
104,000
69,000
99,000
89,000
98,000
98,00089,00099,00069,000104,00099,000104,00074,00084,00087,00084,00062,00091,00091,00094,00080,00091,00087,00081,000000000000
> Total Liabilities 
24,201,000
23,870,000
23,009,000
22,039,000
21,555,000
21,070,000
20,933,000
20,393,000
19,655,000
21,042,000
21,994,000
23,885,000
25,898,000
26,143,000
25,796,000
25,236,000
24,779,000
24,908,000
23,784,000
23,157,000
23,946,000
23,245,000
22,688,000
22,596,000
22,521,000
22,407,000
22,010,000
21,611,000
21,611,00022,010,00022,407,00022,521,00022,596,00022,688,00023,245,00023,946,00023,157,00023,784,00024,908,00024,779,00025,236,00025,796,00026,143,00025,898,00023,885,00021,994,00021,042,00019,655,00020,393,00020,933,00021,070,00021,555,00022,039,00023,009,00023,870,00024,201,000
   > Total Current Liabilities 
9,086,000
9,330,000
8,931,000
8,180,000
8,635,000
8,533,000
8,267,000
8,966,000
8,517,000
11,194,000
10,494,000
9,655,000
11,842,000
10,764,000
10,080,000
9,709,000
9,231,000
10,652,000
9,820,000
9,793,000
10,432,000
10,207,000
9,718,000
9,412,000
9,513,000
9,556,000
8,846,000
8,685,000
8,685,0008,846,0009,556,0009,513,0009,412,0009,718,00010,207,00010,432,0009,793,0009,820,00010,652,0009,231,0009,709,00010,080,00010,764,00011,842,0009,655,00010,494,00011,194,0008,517,0008,966,0008,267,0008,533,0008,635,0008,180,0008,931,0009,330,0009,086,000
       Short-term Debt 
12,597,000
12,259,000
12,380,000
2,550,000
1,184,000
2,199,000
2,281,000
2,960,000
1,276,000
3,609,000
3,605,000
2,894,000
4,423,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000004,423,0002,894,0003,605,0003,609,0001,276,0002,960,0002,281,0002,199,0001,184,0002,550,00012,380,00012,259,00012,597,000
       Short Long Term Debt 
12,597,000
12,259,000
12,380,000
2,550,000
1,184,000
2,199,000
2,281,000
2,960,000
1,276,000
3,609,000
3,605,000
2,894,000
4,423,000
0
0
0
2,182,000
0
0
0
2,379,000
0
0
0
1,073,000
0
0
0
0001,073,0000002,379,0000002,182,0000004,423,0002,894,0003,605,0003,609,0001,276,0002,960,0002,281,0002,199,0001,184,0002,550,00012,380,00012,259,00012,597,000
       Accounts payable 
2,048,000
1,933,000
1,973,000
1,934,000
2,195,000
2,072,000
2,074,000
2,057,000
1,766,000
1,633,000
1,737,000
1,736,000
2,054,000
1,807,000
1,764,000
1,684,000
1,095,000
2,711,000
2,107,000
2,132,000
1,542,000
2,356,000
2,456,000
2,445,000
1,595,000
2,326,000
2,403,000
2,244,000
2,244,0002,403,0002,326,0001,595,0002,445,0002,456,0002,356,0001,542,0002,132,0002,107,0002,711,0001,095,0001,684,0001,764,0001,807,0002,054,0001,736,0001,737,0001,633,0001,766,0002,057,0002,074,0002,072,0002,195,0001,934,0001,973,0001,933,0002,048,000
       Other Current Liabilities 
2,146,000
3,500,000
2,730,000
2,883,000
2,458,000
3,603,000
2,880,000
2,943,000
3,274,000
1,863,000
1,629,000
1,688,000
4,064,000
5,158,000
4,227,000
4,236,000
4,503,000
4,594,000
4,291,000
4,700,000
4,800,000
5,332,000
4,662,000
4,976,000
5,160,000
2,756,000
4,647,000
1,619,000
1,619,0004,647,0002,756,0005,160,0004,976,0004,662,0005,332,0004,800,0004,700,0004,291,0004,594,0004,503,0004,236,0004,227,0005,158,0004,064,0001,688,0001,629,0001,863,0003,274,0002,943,0002,880,0003,603,0002,458,0002,883,0002,730,0003,500,0002,146,000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
9,848,000
11,500,000
14,230,000
14,056,000
15,379,000
15,716,000
15,527,000
15,548,000
14,256,000
13,964,000
13,364,000
13,514,000
13,038,000
12,970,000
13,184,000
13,008,000
12,851,000
13,164,000
12,926,000
12,926,00013,164,00012,851,00013,008,00013,184,00012,970,00013,038,00013,514,00013,364,00013,964,00014,256,00015,548,00015,527,00015,716,00015,379,00014,056,00014,230,00011,500,0009,848,000000000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
0
0
567,000
0
0
0
439,000
0
0
0
459,000
0
0
0
491,000
0
0
0
000491,000000459,000000439,000000567,000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
227,000
226,000
225,000
2,000
91,000
88,000
111,000
-1,000
40,000
30,000
15,000
0
15,000
16,000
17,000
2,000
21,000
20,000
18,000
18,00020,00021,0002,00017,00016,00015,000015,00030,00040,000-1,000111,00088,00091,0002,000225,000226,000227,000000000000
> Total Stockholder Equity
13,989,000
14,418,000
13,706,000
13,731,000
14,003,000
14,045,000
14,834,000
15,283,000
17,200,000
17,640,000
17,550,000
18,158,000
17,865,000
18,556,000
17,982,000
17,928,000
16,946,000
18,916,000
19,293,000
20,607,000
21,338,000
22,919,000
25,955,000
28,260,000
25,927,000
26,149,000
26,701,000
28,222,000
28,222,00026,701,00026,149,00025,927,00028,260,00025,955,00022,919,00021,338,00020,607,00019,293,00018,916,00016,946,00017,928,00017,982,00018,556,00017,865,00018,158,00017,550,00017,640,00017,200,00015,283,00014,834,00014,045,00014,003,00013,731,00013,706,00014,418,00013,989,000
   Common Stock
565,000
565,000
565,000
565,000
565,000
565,000
565,000
565,000
565,000
565,000
565,000
565,000
565,000
565,000
565,000
565,000
565,000
565,000
565,000
565,000
565,000
565,000
565,000
565,000
565,000
0
565,000
0
0565,0000565,000565,000565,000565,000565,000565,000565,000565,000565,000565,000565,000565,000565,000565,000565,000565,000565,000565,000565,000565,000565,000565,000565,000565,000565,000
   Retained Earnings 
8,049,000
8,570,000
8,835,000
9,481,000
9,901,000
10,270,000
10,350,000
10,706,000
12,525,000
11,294,000
11,410,000
11,314,000
13,157,000
13,593,000
13,779,000
14,579,000
14,452,000
15,200,000
15,768,000
16,520,000
16,610,000
16,450,000
18,015,000
18,825,000
18,811,000
19,250,000
19,760,000
20,711,000
20,711,00019,760,00019,250,00018,811,00018,825,00018,015,00016,450,00016,610,00016,520,00015,768,00015,200,00014,452,00014,579,00013,779,00013,593,00013,157,00011,314,00011,410,00011,294,00012,525,00010,706,00010,350,00010,270,0009,901,0009,481,0008,835,0008,570,0008,049,000
   Capital Surplus 0000000000000000000000000000
   Treasury Stock0000000000000000000000000000
   Other Stockholders Equity 
1,561,000
1,469,000
492,000
-129,000
-277,000
-604,000
105,000
198,000
296,000
547,000
147,000
412,000
329,000
584,000
-176,000
-1,030,000
-1,885,000
-663,000
-854,000
-292,000
349,000
2,090,000
3,561,000
5,056,000
2,737,000
0
2,562,000
0
02,562,00002,737,0005,056,0003,561,0002,090,000349,000-292,000-854,000-663,000-1,885,000-1,030,000-176,000584,000329,000412,000147,000547,000296,000198,000105,000-604,000-277,000-129,000492,0001,469,0001,561,000



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue21,428,000
Cost of Revenue-8,557,000
Gross Profit12,871,00012,871,000
 
Operating Income (+$)
Gross Profit12,871,000
Operating Expense-17,241,000
Operating Income4,187,000-4,370,000
 
Operating Expense (+$)
Research Development2,473,000
Selling General Administrative5,321,000
Selling And Marketing Expenses-
Operating Expense17,241,0007,794,000
 
Net Interest Income (+$)
Interest Income127,000
Interest Expense-299,000
Other Finance Cost-0
Net Interest Income-172,000
 
Pretax Income (+$)
Operating Income4,187,000
Net Interest Income-172,000
Other Non-Operating Income Expenses-
Income Before Tax (EBT)3,682,0004,187,000
EBIT - interestExpense = -299,000
2,893,000
3,192,000
Interest Expense299,000
Earnings Before Interest and Taxes (EBIT)-3,981,000
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax3,682,000
Tax Provision-777,000
Net Income From Continuing Ops2,905,0002,905,000
Net Income2,893,000
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-172,000
 

Technical Analysis of Merck & Company Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Merck & Company Inc. The general trend of Merck & Company Inc is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Merck & Company Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Merck & Company Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 163.55 < 163.85 < 170.70.

The bearish price targets are: 155.45 > 154.45 > 146.75.

Tweet this
Merck & Company Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Merck & Company Inc. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Merck & Company Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Merck & Company Inc. The current macd is 1.48500596.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Merck & Company Inc price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Merck & Company Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Merck & Company Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Merck & Company Inc Daily Moving Average Convergence/Divergence (MACD) ChartMerck & Company Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Merck & Company Inc. The current adx is 14.61.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Merck & Company Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Merck & Company Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Merck & Company Inc. The current sar is 155.98.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Merck & Company Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Merck & Company Inc. The current rsi is 60.58. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Merck & Company Inc Daily Relative Strength Index (RSI) ChartMerck & Company Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Merck & Company Inc. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Merck & Company Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Merck & Company Inc Daily Stochastic Oscillator ChartMerck & Company Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Merck & Company Inc. The current cci is 178.68.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Merck & Company Inc Daily Commodity Channel Index (CCI) ChartMerck & Company Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Merck & Company Inc. The current cmo is 25.57.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Merck & Company Inc Daily Chande Momentum Oscillator (CMO) ChartMerck & Company Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Merck & Company Inc. The current willr is -18.57923497.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Merck & Company Inc Daily Williams %R ChartMerck & Company Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Merck & Company Inc.

Merck & Company Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Merck & Company Inc. The current atr is 2.59510486.

Merck & Company Inc Daily Average True Range (ATR) ChartMerck & Company Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Merck & Company Inc. The current obv is -80,800.

Merck & Company Inc Daily On-Balance Volume (OBV) ChartMerck & Company Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Merck & Company Inc. The current mfi is 43.56.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Merck & Company Inc Daily Money Flow Index (MFI) ChartMerck & Company Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Merck & Company Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-10STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-17MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-20BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-22MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-12BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-23BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-27MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-04MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Merck & Company Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Merck & Company Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5060.576
Ma 20Greater thanMa 50158.760
Ma 50Greater thanMa 100155.043
Ma 100Greater thanMa 200151.696
OpenGreater thanClose160.000
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Merck & Company Inc with someone you think should read this too:
  • Are you bullish or bearish on Merck & Company Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Merck & Company Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Merck & Company Inc

I send you an email if I find something interesting about Merck & Company Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Merck & Company Inc.

Receive notifications about Merck & Company Inc in your mailbox!